StockNews.com began coverage on shares of Seagen (NASDAQ:SGEN – Free Report) in a research note released on Friday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Other research analysts have also recently issued research reports about the company. Morgan Stanley reissued an equal weight rating and issued a $229.00 price target […]
Shares of Seagen Inc. (NASDAQ:SGEN – Get Free Report) have received a consensus recommendation of “Hold” from the seventeen analysts that are currently covering the firm, Marketbeat Ratings reports. Eleven analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The average 12-month price objective among […]
StockNews.com initiated coverage on shares of Seagen (NASDAQ:SGEN – Free Report) in a report released on Tuesday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Other equities research analysts have also issued research reports about the stock. Truist Financial reaffirmed a hold rating and set a $229.00 target price on shares […]
Twin Securities Inc. bought a new stake in shares of Seagen Inc. (NASDAQ:SGEN – Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund bought 100,599 shares of the biotechnology company’s stock, valued at approximately $19,361,000. Seagen makes up 10.7% of Twin Securities Inc.’s portfolio, […]
Verity Asset Management Inc. lessened its position in Seagen Inc. (NASDAQ:SGEN – Free Report) by 2.4% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 5,929 shares of the biotechnology company’s stock after selling 147 shares during the period. Verity Asset Management Inc.’s holdings in Seagen were worth […]